Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kenji Oonaka is active.

Publication


Featured researches published by Kenji Oonaka.


The Journal of the Japanese Association for Infectious Diseases | 2003

ハトおよびカラスからのVero毒素産生性大腸菌 (VTEC) の分離および血清型

Masafumi Fukuyama; Katunori Furuhata; Kenji Oonaka; Shinji Sakata; Motonobu Hara; Youji Kakuno; Takeshi Itoh; Akemi Kai; Hiromi Obata; Tadao Watanabe

To clarify the source and route of infection with Vero toxin-producing Escherichia coli (VTEC) in humans, we sampled gastrointestinal contents and isolated VTEC from wild birds captured to exterminate harmful birds between August 1997 and January 1998. Pigeons were caught in Sagamihara-shi and crows were caught in Sagamihara-shi, Kawasaki-shi, Yokohama-shi, and the Tokyo metropolitan area. The following results were obtained. 1) VTEC was isolated from 32 of 521 birds (6.1%) examined. Among pigeons, VTEC was isolated from 25 of 262 birds (9.5%) captured in Sagamihara-shi. Among crows, VTEC was isolated from 7 of 184 birds (3.8%) captured in Sagamihara-shi, but not isolated from any bird of 11.4, and 60 birds captured in Yokohama-shi, Kawasaki-shi, and the Tokyo metropolitan area, respectively. 2) Toxin was typed in 33 isolates. There were four VT1-producing isolates (6.5%), 27 VT2-producing isolates (88.7%), and two VT1, VT2-producing isolates (4.8%). 3) The serotypes of the isolates were: O78: H-, 10; O152: H-, 7; O153: H19.2; O164: H-, 1; O128: H-, 1; O164/143: H-, and O1: HUT, 1. The serotype was unknown in 10 isolates. Among 10 isolates for which the serotype could not be determined, auto-aggregation was observed in one isolate. 4) EaeA was investigated in the 33 isolates, and 31 isolates (93.9%) possessed eaeA. The above findings showed that strains with same toxin types and serotypes of human diarrhea-derived VTEC were isolated from pigeons and crows, and the isolates frequently possessed eaeA, which is considered to have an important association with its pathology, suggesting that birds are involved in VTEC infection in humans as a source of infection.


Archives of Virology | 2012

Biology of fowl adenovirus type 1 infection of heterologous cells

Satoshi Taharaguchi; Rina Fukazawa; Miho Kitazume; Hayato Harima; Kensuke Taira; Kenji Oonaka; Motonobu Hara

The JM1/1 strain of fowl adenovirus (FAV) serotype 1 isolated from gizzard erosion was used to investigate the biology of FAV in homologous (susceptible) and heterologous cells. The FAV JM1/1 strain is capable of efficient multiplication in primary chicken kidney (CK) cells, but not in Crandell-Rees feline kidney (CRFK) cells or Vero cells. FAV adsorption in heterologous cells was slightly higher than in CK cells. An early gene encoding a DNA-binding protein and a late gene encoding the hexon protein were expressed in CK cells. Only the early gene was expressed in Vero cells. Neither of these genes was expressed in CRFK cells. These results suggest that the virus was unable to multiply effectively due to suppression of viral gene expression in the heterologous cells used in this study.


Biocontrol Science | 2017

In vitro Anti-Influenza Virus Activity of Agaricus brasiliensis KA21

Nao Eguchi; Kan Fujino; Khompakorn Thanasut; Motoko Taharaguchi; Masuro Motoi; Akitomo Motoi; Kenji Oonaka; Satoshi Taharaguchi

 Agaricus is known to have immunostimulatory and anti-tumor effects. However, the antiviral effects of Agaricus have not yet been examined. In the present study, the antiviral effects of an extract of Agaricus brasiliensis KA21 (AE) on the H1N1 influenza virus (PR8 strain) were investigated. The anti-influenza virus effects of AE were examined by using the plaque formation inhibition test. AE inhibited the plaque formation of PR8 in a dose-dependent manner: 98 and 50% (IC50) inhibition at 2.5 and 0.99 mg/mL, respectively. To elucidate the mechanisms of AE, the direct actions and adsorption and invasion inhibition of AE were examined, and were found to have no inhibitory effect on PR8 infection. Thus, in vitro antiviral effects may somehow inhibit PR8 after the viral invasion of cells. These results demonstrated that it is expected that AE can effectively prevent the spread of the influenza virus.


Japanese Journal of Infectious Diseases | 2010

Powder infant formula milk contaminated with Enterobacter sakazakii.

Kenji Oonaka; Katsunori Furuhata; Motonobu Hara; Masafumi Fukuyama


The Journal of the Japanese Association for Infectious Diseases | 1999

[Study on the verotoxin-producing Escherichia coli--isolation of the bacteria from deer dung].

Masafumi Fukuyama; Yokoyama R; Shinji Sakata; Katunori Furuhata; Kenji Oonaka; Motonobu Hara; Yoshiharu Satoh; Kiyoshi Tabuchi; Takeshi Itoh; Akemi Kai; Motoo Matsuda


Journal of Infection and Chemotherapy | 2010

Identification of Legionella londiniensis isolated from hot spring water samples in Shizuoka, Japan, and cytotoxicity of isolates

Katsunori Furuhata; Kikumi Ogihara; Naoto Ishizaki; Kenji Oonaka; Yoshihiro Yoshida; Keiichi Goto; Motonobu Hara; Hiroshi Miyamoto; Shin-ichi Yoshida; Masafumi Fukuyama


The Journal of the Japanese Association for Infectious Diseases | 2003

[Isolation and serotyping of Vero toxin-producing Escherichia coli (VTEC) from pig].

Masafumi Fukuyama; Katunori Furuhata; Kenji Oonaka; Reiko Yakiwara; Takeshi Koizumi; Motonobu Hara; Chikaku Dogasaki; Tokihiro Shimada; Takashi Kuribayashi; Muneo Nakazawa; Tadao Watanabe


Biocontrol Science | 2009

Growth in Acanthamoeba sp. and antibiotic susceptibility of Legionella micdadei isolated from hot spring water samples.

Katsunori Furuhata; Kikumi Ogihara; Rumi Okuno; Kenji Oonaka; Masafumi Fukuyama


The Journal of Antibiotics | 2000

Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis

Masafumi Fukuyama; Katunori Furuhata; Kenji Oonaka; Tetsuro Hara; Keisuke Sunakawa


The Journal of the Japanese Association for Infectious Diseases | 2004

[A basic study of Vibrio vulnificus infection: serotyping and drug sensitivity test of environment-derived strains and human clinical isolates].

Kenji Oonaka; Katsunori Furuhata; Akio Kiuchi; Motonobu Hara; Masafumi Fukuyama

Collaboration


Dive into the Kenji Oonaka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akitomo Motoi

Tokyo University of Pharmacy and Life Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge